- If you have been wondering whether Veeva Systems at around US$184 per share looks like a bargain or not, this breakdown will help you weigh the price against the underlying business.
- The stock has seen mixed returns, with a 5.7% gain over the last 30 days, set against a 22.4% decline over the past year and a 16.2% decline year to date.
- Recent coverage has focused on how investors are reassessing higher growth software names, with attention on valuation discipline and selectivity across healthcare and cloud software stocks. For Veeva Systems, this context helps explain why the share price has been under pressure even as interest in quality software names remains high.
- Veeva Systems holds a valuation score of 3 out of 6, and the rest of this article will walk through how different valuation approaches arrive at that number and point to a way of understanding valuation that goes beyond a single score.
Approach 1: Veeva Systems Discounted Cash Flow (DCF) Analysis
A Discounted Cash Flow, or DCF, model takes projected future cash flows, discounts them back to today using a required return, and sums them to estimate what the business could be worth per share right now.
For Veeva Systems, the model used is a 2 Stage Free Cash Flow to Equity approach, based on cash flows in $. The latest twelve month free cash flow is about $1.39b. Analysts provide explicit free cash flow estimates out to 2031, with Simply Wall St extrapolating further years beyond those analyst inputs. By 2031, projected free cash flow used in the model is $2.44b, with intermediate annual projections between 2026 and 2035 ranging from roughly $1.33b to $3.17b before discounting.
After discounting these projected cash flows back to today, the DCF model arrives at an estimated intrinsic value of about $269.48 per share, compared with the current share price of around $184. On this basis, the model implies the stock is about 31.7% undervalued.
Result: UNDERVALUED
Our Discounted Cash Flow (DCF) analysis suggests Veeva Systems is undervalued by 31.7%. Track this in your watchlist or portfolio, or discover 49 more high quality undervalued stocks.
Approach 2: Veeva Systems Price vs Earnings
For profitable companies like Veeva Systems, the P/E ratio is a commonly used gauge because it links what you pay for each share to the earnings that the business is currently generating. It gives you a simple way to relate share price to underlying profitability.
What counts as a “normal” P/E often reflects how fast earnings are expected to grow and how risky those earnings appear. Higher expected growth or lower perceived risk can justify a higher P/E, while slower growth or higher risk usually point to a lower multiple.
Veeva Systems currently trades on a P/E of 33.28x. That sits above the Healthcare Services industry average of about 29.70x and the peer average of 29.67x. Simply Wall St also calculates a proprietary “Fair Ratio” for Veeva Systems of 31.02x, which is the P/E it might trade on given factors such as its earnings growth profile, industry, profit margins, market cap and risk characteristics.
Because the Fair Ratio blends these company specific factors, it can give a more tailored view than a simple comparison with peers or the broad industry. With Veeva Systems at 33.28x against a Fair Ratio of 31.02x, the shares look somewhat expensive on this metric.
Result: OVERVALUED
P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 20 top founder-led companies.
Upgrade Your Decision Making: Choose your Veeva Systems Narrative
Earlier it was mentioned that there is an even better way to understand valuation, so Narratives are introduced as a simple story you choose about Veeva Systems that ties your view of its future revenue, earnings and margins to a fair value, then compares that to the current price to help inform your decision making.
On Simply Wall St, Narratives sit inside the Community page and let you connect the qualitative story you believe, such as AI agents improving workflows or CRM competition limiting growth, directly to a set of financial forecasts and an implied fair value.
These Narratives are refreshed automatically when new information comes in, such as earnings updates, guidance changes or new analyst targets. This helps keep your view of fair value aligned with the latest data without you needing to rebuild a model each time.
For Veeva Systems, one investor might align with a more optimistic Narrative using a fair value around US$380.00, while another might prefer a cautious Narrative closer to US$232.80. By comparing each fair value to the live share price, you can decide which story you find more reasonable and how that influences your own next step.
Do you think there's more to the story for Veeva Systems? Head over to our Community to see what others are saying!
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com